Freeline Therapeutics Holdings Plc Adss (FRLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 0 | 28,171 | 0 | 0 | 0 |
| Operating Income | N/A | -28,171 | N/A | N/A | N/A |
| Other Income | 0 | 1,460 | 0 | 0 | 0 |
| Pre-tax Income | 0 | -26,711 | 0 | 0 | 0 |
| Income Tax | N/A | 22 | N/A | N/A | N/A |
| Net Income Continuous | N/A | -26,733 | N/A | N/A | N/A |
| Net Income | $N/A | $-26,733 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | N/A | -0.63 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | N/A | -0.63 | N/A | N/A | N/A |
| EPS Diluted Total Ops | N/A | -0.63 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | N/A | -0.63 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.32 | -9.40 | -0.97 | -0.86 | -1.12 |
| EBITDA(a) | $N/A | $-27,630 | $N/A | $N/A | $N/A |